Cookie preferences

Choose what we may use. Strictly necessary cookies keep you signed in and can't be turned off; everything else is your call and changes nothing about how the site works. You can change your mind any time from the footer.

Marketing attribution for pharma and life sciences companies

Which channels produced ordering accounts?

Match ordering accounts and their repeat revenue to the campaigns, congresses and content that produced the first order.

  • No card required
  • Nothing to install
  • Cancel anytime
Pharma & Life Sciences workspace FY2026 Sample data
Order revenue traced to a channel

$3,100,000 50% of $6,200,000 paid

  • Content & SEO $1,302,000 · 21%
  • Congresses & events $1,054,000 · 17%
  • Email marketing $744,000 · 12%
  • Direct / Unknown $3,100,000 · 50%
Direct / Unknown is shown, never shared out across the channels above.
Content & SEO · LeadFY2026 14 · (•••) •••-0134
Closed sale · FY2026 27$3,160
Matched · high confidence

The blind spot

What's actually happening

Life sciences purchasing is repeat, catalog-driven and institutional. First-order attribution describes a fraction of what a channel is worth.

What you get

Built for pharma and life sciences companies.

Closed revenue, not pipeline stages

Channels are ordered by booked revenue rather than by volume, which is usually a different list from the one your ad account shows.

Cycles longer than any attribution window

The gap between the inquiry and the order costs you nothing — there is no window to expire and nothing decays.

Defensible in a board pack

High-confidence matches count automatically; a partial link is queued for review rather than quietly counted as an order.

A worked example

The number you can take into a budget meeting.

Not impressions, not leads, not cost per click. Closed revenue, by the channel that produced it, for a period you choose — with the portion we could not trace shown rather than quietly shared out across your paid channels.

Total revenue$6,200,000paid order revenue
Attributed to a channel$3,100,00050% of revenue
Average deal$3,160per paid sale
Match rate50%of sales matched
ChannelSalesRevenueShare%
Content & SEO412$1,302,00021%
Congresses & events334$1,054,00017%
Email marketing236$744,00012%
Direct / Unknown982$3,100,00050%
01

A first order is the beginning of a reordering account

A laboratory that orders once can go on reordering for years. Attribution that credits only the first order misprices every acquisition channel the business has.

Because the match is on the account, every reorder credits the original channel — which normally reveals that content and technical resources, not paid media, produce the accounts that keep ordering.

02

Technical content is the channel, and it looks like a cost center

Application notes, protocols and technical documentation are what scientists actually use to choose a supplier, and they are budgeted as content rather than as acquisition.

With download or registration lists added to the lead file, each tagged with its source, technical content ranks on order revenue against paid media. In this sector it may well win, and being able to show that protects the budget.

03

Distributors and procurement portals stand between you and the buyer

A large share of laboratory purchasing never touches a direct order. A scientist specifies a catalog number, the institution's procurement system routes it through a preferred distributor, and the supplier receives an order from an intermediary carrying none of the researcher's details. The demand was created by the supplier's own content and the transaction record belongs to somebody else, which is the structural reason this sector's marketing is so hard to value. It is not that the buying journey is unusually long; it is that its two ends are recorded in different companies' systems.

Where the supplier holds an end-user contact — a quote request, a technical support ticket, a sample request, a registration — that contact can be matched even when the order arrived through a distributor. Carrying both the distributor and the end-user contact in the revenue file lets the report be read either way: which channels produce distributor volume, and which produce the scientists who specify. Those are different questions, and the second is usually the one marketing is funded to answer. Where only the distributor's details exist, the revenue stays honestly unattributed rather than credited on a guess.

Sell-through reports, in which a distributor shares which end users bought what, close most of the remaining gap and are worth asking for. They upload exactly like any other revenue file. Where they cannot be obtained, the useful fallback is to measure the distributor relationship itself as a channel, ranked on the revenue it produced against the cost of supporting it — co-marketing, catalog fees, training, sample stock. That comparison is rarely made and becomes simple arithmetic once the data sits in one place. It also tends to be the conversation that gets a sell-through report agreed.

04

Grant cycles, year-end budgets and a scientist who moves

Laboratory purchasing is governed by funding rather than by demand. A grant is awarded, a project starts, consumables are ordered for its duration, and the ordering stops when the money does. Institutional budget years produce a spending surge before a fixed date every year that has nothing to do with anybody's advertising. A channel evaluated in the wrong month will look either brilliant or useless, and neither reading is about the channel. The only defense is comparing the same period across years, which works because nothing had to be running at the time.

The other thing funding does is move people. A principal investigator takes a post at another institution and the ordering account effectively relocates, along with purchasing habits and supplier preferences built over a decade. The old account goes quiet, a new one appears, and every acquisition metric reads that as one loss and one win when it was neither. Where the person's email follows them the match follows too, and the new account credits the channel that produced the original relationship. Where it does not, the new revenue sits in Direct / Unknown, which is honest and also a signal worth acting on.

Both effects argue for the same discipline: run long ranges and compare like with like. A single quarter in this sector describes the funding calendar more faithfully than it describes anything a marketing team did. Years compared against years, with a product or research-area column present so a surge in one category does not carry the appearance of the rest, is the reading that survives being questioned by somebody who knows how the money arrives. It is also the reading that keeps a content budget alive through a planning round, and those budgets are cut on absent evidence far more often than on contrary evidence.

05

What the compliance conversation actually requires

Regulated businesses ask three questions about a tool like this, and the answers are short. What leaves our systems: a contact detail, an amount and a date, plus a product or location column if you choose to map one. What happens to it: encrypted in transit and at rest, held in a workspace isolated from every other customer, and deleted outright when you ask rather than marked as deleted. Who processes it: we act as a data processor and a DPA is available. Nothing else is required, nothing else should be sent, and the shortest export is the fastest one to approve.

The fourth question, asked less often and mattering more, is whether the output can be taken apart. It can. Every counted match traces back to two rows you supplied, nothing is modeled, and revenue that matches nothing is reported as Direct / Unknown rather than distributed across the paid channels to improve a headline. A figure that cannot be reconstructed is not usable in an environment where somebody may later ask exactly how it was produced. That constraint is the reason only high-confidence matches count automatically and weaker ones wait for a person to decide.

There is also the question of what does not happen. Nothing is installed on a website, no script runs in a visitor's browser, no API credential is issued and no system is connected to another. The inputs are two CSV exports produced by people who already have the right to produce them. For an organization where a new integration means a vendor assessment measured in months, that difference usually decides whether the exercise happens at all. It is also why a team can test the idea on last year's data before anybody approves anything ongoing, and unwind nothing if the result is dull.

Why it matters

What changes when you can prove it.

You stop defending the budget and start growing it

"We generated 400 leads" invites an argument. "This channel closed $186,400 last quarter, here is the reconciliation" ends one. The teams that can show closed revenue by channel are the teams that get the next increase approved, because they are asking with evidence rather than with conviction.

You can cut the wrong channel without a fight

Killing spend is politically harder than adding it, because someone always owns the channel being cut. A number that reconciles to the sales export takes the argument out of the room — you are not overruling a colleague's judgment, you are reading the same ledger they are.

Your reporting survives the finance review

Platform-reported conversions do not reconcile to revenue, and eventually someone in finance notices. Reporting built from your own closed-sales export starts from the number finance already trusts, which is why it holds up when it is checked.

You answer in an afternoon, not a quarter

Because this reconciles exports rather than tracking visitors, it works on months that have already closed. You are not instrumenting now to learn something in ninety days — you can answer for last quarter today, which is usually when the question is being asked.

Honest answers

The pushback we hear from Pharma & Life Sciences.

They say

Our customers reorder for years.

We say

Which is why reorders must credit the original channel. That is where the value of an acquisition actually is.

They say

We sell to institutions.

We say

Matching works on the institutional contact's email or phone; the account name is not used to match.

They say

We operate in a regulated, audited environment.

We say

Nothing is inferred and nothing is redistributed. Every counted match traces back to two records you supplied.

Pricing

Flat monthly pricing. No per-call fees.

The price here is the price on the invoice, plus any sales tax that applies — no per-call, per-minute or per-form fees. Enterprise usually fits pharmaceutical and life sciences suppliers — ten seats for the team and the highest monthly record allowance, since a year of closed deals is a lot of rows.

Enterprise

One business closing at volume

$499/mo

billed monthly

  • 1 workspace · 10 seats
  • 25,000 sales records / month
  • 24-month history
  • Campaign drill-down and period comparison
  • Single sign-on through your identity provider
  • Your logo on every report
  • Roles, permissions and guided onboarding
  • Priority support

Questions

Questions we get about Pharma & Life Sciences.

Anything else? Talk to us — a person answers, usually the same day.

Orders: a contact email, the order value, and a date.

Start today

Stop guessing which ads pay off.

Upload two exports and see your real revenue by channel in minutes. 14 days free, no card.